Fairvalue-Calculator Fairvalue-Calculator
EN DE

Sisram Medical Ltd (SRAMF) Fair Value & Analysis

Healthcare · US · Market cap $205M

Price$0.4383
Fair Value$0.8900
Upside+103.1%
Quality90/100
Evidence: Medium Range $0.6700 – $1.12

Fair value as of: Jun 25, 2026

Analysis

Sisram Medical Ltd (SRAMF) currently trades at $0.4383, while our model-based Fair Value estimate is $0.8900 — implying the stock looks roughly 103.1% undervalued today. We read business quality at 90/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

Sisram Medical Ltd, together with its subsidiaries, engages in the research, design, development, manufacture, sale, and marketing of medical aesthetics and dental equipment, home-use devices, injectables, and cosmeceutical products in the Asia Pacific, North America, Europe, the Middle East, Africa, and Latin America. The company offers a portfolio of products and treatments for clinical aesthetic indications, including hair removal, skin rejuvenation, acne and acne scars, trans-epidermal delivery, face and body contouring, cellulite treatment, stretch marks, vascular and pigmented lesions, pigmentation and skin resurfacing, fat grafting, dermal facial fillers, skin tissue remodeling, injectables, personal care, aesthetic dentistry, hydradermabrasion, blepharoplasty (nonsurgical eyelid lift), liposuction, feminine health, and sexual rehabilitation. It also engages in pharmaceutical research and development activities. The company offers its products under the Alma, LMNT, Copulla, P…

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Sisram Medical Ltd (SRAMF) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $0.8900 versus a price of $0.4383 — about +103% (undervalued). Model-based estimate, not financial advice.
What is the fair value of SRAMF?
Our 21-model fair value for Sisram Medical Ltd is $0.8900 (as of Jun 25, 2026), built from audited fundamentals. The current price is $0.4383.
What is the quality score of SRAMF?
Sisram Medical Ltd has a Quality Score of 90/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.